EXCLUSIVE: Healthshare Org Urges Incoming Trump Admin To Make ‘Radical’ Change To FDA, Healthcare System
Solidarity HealthShare is calling on the incoming Trump Administration to fix the “nation’s broken healthcare system” with widespread changes to the Food and Drug Administration (FDA).
The current healthcare system is in need of “radical” overhaul of FDA restrictions and a refocus on personalized approaches that target the root causes of chronic diseases, according to a letter first obtained by the Daily Caller News Foundation. President-elect Donald Trump has vowed to tackle health issues in the country as part of the Make America Healthy Again (MAHA) effort alongside former independent presidential candidate Robert F. Kennedy Jr., who Trump recently nominated for secretary of Health and Human Services (HHS).
“Over the past four years, Americans have seen the cost of their healthcare rise exponentially under a health system and an FDA plagued by waste and inefficiency even as the quality of care has plummeted,” Solidarity HealthShare’s letter reads. “For this reason, we respectfully request you thoroughly assess our current healthcare system which is no longer serving patient needs.”
Naloxone, a medication approved by the Food and Drug Administration (FDA) designed to rapidly reverse opioid overdose is displayed during a demonstration intended to educate Health and Human Services (HHS) Department staff and the public on the medication that “rapidly reverses the effects of opioid overdose” at HHS in Washington, DC, on September 8, 2023. (Photo by OLIVIER DOULIERY/AFP via Getty Images)
The organization is urging the Trump Administration to dissuade the healthcare industry from treating symptoms of chronic diseases such as cancer and heart disease instead of using comprehensive diagnostics and treatments that address the root causes of illness and to roll back FDA restrictions on technologies and treatments. By “overhauling the FDA’s patent restrictions,” the U.S. could also allow for alternative treatments and “unleash medical innovation.”
The FDA’s current patent restrictions are responsible for some of the soaring prices in medicine by blocking off-brand versions of products from patent approvals and preventing competition that keeps prices low, according to America First Policy Institute.
Solidarity also names “Big Pharma, Big Insurance and Big Hospital Systems” as contributing to the bureaucratization of medicine.
Environmental concerns also prompted Solidarity’s letter, which encourages the future administration to implement harsher regulations on air and water pollutants that contribute to Americans’ deteriorating health.
RFK Jr. has already pledged to remove fluoride from water and combat harmful chemical pesticides.
On January 20, the Trump White House will advise all U.S. water systems to remove fluoride from public water. Fluoride is an industrial waste associated with arthritis, bone fractures, bone cancer, IQ loss, neurodevelopmental disorders, and thyroid disease. President…
— Robert F. Kennedy Jr (@RobertKennedyJr) November 2, 2024
The Trump Administration should also push back on easily-accessed processed, nutrient-deficient foods and increase access to healthier options, the letter states. (RELATED: Biden-Harris Health Department Spent Tens Of Millions Annually On DEI)
Solidarity concluded its letter by encouraging the Trump administration to promote “each person’s God-given dignity and inherent right to life” and protect the elderly, unborn and chronically ill.
All content created by the Daily Caller News Foundation, an independent and nonpartisan newswire service, is available without charge to any legitimate news publisher that can provide a large audience. All republished articles must include our logo, our reporter’s byline and their DCNF affiliation. For any questions about our guidelines or partnering with us, please contact [email protected].
